Global Interventional Tumor Ablation Market Size To Worth USD 4.43 Billion By 2033 | CAGR of 9.30%
Category: HealthcareGlobal Interventional Tumor Ablation Market Size To Worth USD 4.43 Billion By 2033
According to a research report published by Spherical Insights & Consulting, the Global Interventional Tumor Ablation Market size was valued at USD 1.82 Billion in 2023 and is Expected to reach USD 4.43 Billion by 2033, Growing at a CAGR of 9.30% from 2023 to 2033.
Get more details on this report -
Browse key industry insights spread across 210 pages with 110 Market data tables and figures & charts from the report on the "Global Interventional Tumor Ablation Market Size, Share, and COVID-19 Impact Analysis, By Technology (Radiofrequency Ablation, Microwave Ablation, Cryoablation, and Others), By Application (Liver Cancer, Lung Cancer, Kidney Cancer, Bone Metastasis, and Others), By End-User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033." Get Detailed Report Description Here:https://www.sphericalinsights.com/reports/interventional-tumor-ablation-market
The term "interventional tumor ablation industry" describes the market for treatments that use heat, ice, or sound waves to destroy tumor cells. Among other malignancies, lung, kidney, and liver cancer are treated with these treatments. There are several ways to remove or eradicate tumors without undergoing open surgery. Interventional tumor ablation targets and destroys tumor cells with the least amount of damage to the surrounding healthy cells. the growing interest in radiofrequency ablation, microwave ablation, and cryoablation. People and medical professionals are starting to prefer these less invasive therapies as a result. This trend is well suited to tumor ablation procedures, which, in comparison to standard surgical methods, usually offer faster recovery times and fewer complications while also improving patient outcomes with shorter hospital stays. For patients who may not be the best candidates for surgery, such as those who are elderly or have several diseases, the minimally invasive aspect of these methods is very beneficial. Furthermore, developments in imaging and ablation technology have fueled market expansion. Advances in imaging guidance systems and effective energy delivery have improved tumor ablation therapies' accuracy and safety. The combination of machine learning and artificial intelligence improves treatment results even more. However, The high cost of advanced ablation equipment and treatments limits accessibility, especially in low- and moderate-income communities. A further barrier to industry growth is the lack of skilled healthcare personnel. Inconsistent training and certification among interventional radiologists and oncologists affect care quality and accessibility. Furthermore, a shortage of qualified healthcare workers impedes industry expansion.
The radiofrequency ablation segment secured a significant share in 2023 and is anticipated to grow at a remarkable CAGR during the forecast period.
Based on the technology, the global interventional tumor ablation market is separated into radiofrequency ablation, microwave ablation, cryoablation, and others. Among these, the radiofrequency ablation segment held a significant share in 2023 and is anticipated to grow at a remarkable CAGR during the forecast period. Its efficacy and safety in treating various tumor types are the reasons for this significant share. RFA effectively destroys cancer cells by using high-frequency electrical currents to generate localized heat. RFA is the preferred method due to its precision and relatively low risk, especially for liver and lung cancers. Continuous advancements in RFA devices, such as enhanced electrode designs and real-time monitoring capabilities, are driving market growth and increasing treatment outcomes.
The liver cancer segment held a significant share in 2023 and is expected to grow at a significant CAGR during the forecast period.
Based on the application, the global interventional tumor ablation market is categorized as liver cancer, lung cancer, kidney cancer, bone metastasis, and others. Among these, the liver cancer segment held a significant share in 2023 and is expected to grow at a significant CAGR during the forecast period. This significance is attributed to its high incidence and often late-stage discovery, liver cancer remains one of the most prevalent applications for tumor ablation techniques. Ablation therapies offer a minimally invasive alternative that successfully manages malignancies and enhances patient outcomes for patients who are unable to undergo surgery. Technology advancements in imaging and needle insertion have led to a significant improvement in the success rates of liver tumor ablation, which has stimulated market growth in these areas.
The hospitals segment accounted for the highest share in 2023 and is anticipated to grow at a prominent CAGR during the forecast period.
Based on the end-user, the global interventional tumor ablation market is divided into hospitals, ambulatory surgical centers, specialty clinics, and others. Among these, the hospitals segment accounted for the highest share in 2023 and is anticipated to grow at a prominent CAGR during the forecast period. The existence of skilled healthcare workers and the accessibility of state-of-the-art medical facilities are the main drivers of this segmental expansion. The incorporation of tumor ablation technology into hospital oncology departments, which are often the primary sites for cancer diagnosis and treatment, has been a significant growth driver. The dominance of this market is due to ongoing investments in hospital infrastructure and the adoption of state-of-the-art medical technology.
North America is projected to hold the largest share of the global interventional tumor ablation market over the forecast period.
Get more details on this report -
North America is projected to hold the largest share of the global interventional tumor ablation market over the forecast period. High healthcare spending, the availability of cutting-edge medical technology, and an increasing influence on cancer are the main drivers of this region. Market expansion in this industry is also aided by the existence of top medical device manufacturers, new innovations, and the speed with which operating organizations and end users embrace cutting-edge technology. The United States notably controls a significant share of the North American market due to its well-established healthcare system and strong emphasis on research and development.
The Asia Pacific interventional tumor ablation market is expected to grow with the fastest CAGR during the forecasting period. Stronger healthcare infrastructure, greater healthcare understanding, and the growing effect of cancer all have a substantial impact on this regional rise. Leading the way in this expansion are China, India, and Japan, which have made significant investments in healthcare infrastructure and are putting more emphasis on early cancer identification and treatment. China leads the global market for interventional tumor ablation because of its robust industrial base, supportive policies, and strong domestic demand. In 2024, cancer remained a major health concern in China. It is estimated that the country saw 16.99 million cancer-related fatalities and 32.466 million new instances of the disease. For these high-incidence cases, modern technology-based treatments like as cryoablation, microwave ablation, and radiofrequency ablation are necessary. Additionally, it helped the region's interventional tumor ablation industry grow.
Major key players in the interventional tumor ablation market include Terumo Corporation, Varian Medical Systems, Inc., Johnson & Johnson, EDAP TMS S.A., BTG International Ltd.,Hologic, Inc., Olympus Corporation, Siemens Healthineers AG, AngioDynamics, Inc., Merit Medical Systems, Inc., and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Development
- In March 2023, Galvanize Therapeutics' FDA-cleared Aliya Pulsed Electric Field (PEF) System was studied in Europe and Asia for treating solid tumors. The system induces PEF-mediated cell death and stimulates the immune response against tumors. Positive preclinical and early clinical results highlighted its potential as an effective interventional oncology treatment for soft tissue ablation.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global interventional tumor ablation market based on the below-mentioned segments:
Global Interventional Tumor Ablation Market, By Technology
- Radiofrequency Ablation
- Microwave Ablation
- Cryoablation
- Others
Global Interventional Tumor Ablation Market, By Application
- Liver Cancer
- Lung Cancer
- Kidney Cancer
- Bone Metastasis
- Others
Global Interventional Tumor Ablation Market, By End-User
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Others
Global Interventional Tumor Ablation Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?